The central venous catheters market has seen considerable growth due to a variety of factors.
• The central venous catheters market has seen significant growth in recent years. It will grow from $3.94 billion in 2024 to $4.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%.
The expansion of this market is due to the increasing prevalence of chronic diseases, improved infection control practices, higher demand for intravenous therapy, and increased use in medical emergencies and trauma care.
The central venous catheters market is expected to maintain its strong growth trajectory in upcoming years.
• The central venous catheters market is expected to grow to $6.14 billion by 2029 at a CAGR of 9.2%.
Factors such as the rising incidence of chronic diseases, demand for minimally invasive procedures, and advancements in catheter designs contribute to this growth. Major trends include the adoption of antimicrobial-coated catheters, advancements in bioresorbable materials, and the development of power-injectable CVCs.
The increasing prevalence of kidney diseases is expected to drive the growth of the central venous catheter market. Kidney disease rates are rising due to chronic conditions like diabetes and hypertension, which require treatments like hemodialysis. Central venous catheters provide essential access for dialysis and other treatments. Kidney Research UK reported that 7.19 million people in the UK were affected by kidney disease in 2023, a number expected to grow to 7.61 million by 2033. This rising prevalence is boosting the central venous catheter market.
The central venous catheters market covered in this report is segmented –
1) By Type: Single-lumen, Double-lumen, Triple-lumen, Other Types
2) By Property: Antimicrobial Coated, Non-Antimicrobial Coated
3) By Application: Jugular Vein, Subclavian Vein, Femoral Vein, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single-Lumen: Non-Tunneled Single-Lumen Catheters, Tunneled Single-Lumen Catheters
2) By Double-Lumen: Non-Tunneled Double-Lumen Catheters, Tunneled Double-Lumen Catheters
3) By Triple-Lumen: Non-Tunneled Triple-Lumen Catheters, Tunneled Triple-Lumen Catheters
4) By Other Types: Quad-Lumen Catheters, Peripherally Inserted Central Catheters (PICC)
In the central venous catheter market, companies are focusing on advanced ultrasound systems to improve precision and safety during catheter insertion. These systems offer real-time visualization, enhancing accuracy and reducing complications. For example, in November 2023, US-based Becton, Dickinson, and Company (BD) launched SiteRite 9, a vascular access ultrasound system. The system provides enhanced image quality and includes features like real-time needle tracking and precise catheter navigation, aiming to simplify vascular access procedures and support clinician efficiency.
Major companies operating in the central venous catheters market are:
• Medtronic plc
• Becton
• Dickinson and Company (BD)
• Boston Scientific Corporation
• B. Braun Holding GmbH & Co. KG
• Terumo Corporation
• Edwards Lifesciences Corporation
• Teleflex Incorporated
• Cook Group Incorporated
• ICU Medical Inc.
• Lepu Medical Technology (Beijing) Co. Ltd
• Merit Medical Systems Inc
• Vygon SAS
• AngioDynamics Inc.
• Argon Medical Devices Inc.
• Poly Medicure Limited
• Vogt Medical Vertrieb GmbH
• MedCath Corporation
• GaltNeedleTech Inc.
• Romsons International
• Newtech Medical Devices Private Limited
• NIPRO Medical Corporation
• DemeTECH Corporation
• Scitech Medical Products SA
• Prodimed
• P. K. Scientific & Chemicals
North America was the largest region in the central venous catheters market in 2023. The regions covered in the central venous catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.